Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial
Titel:
Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial
Auteur:
Bekker, Linda-Gail Moodie, Zoe Grunenberg, Nicole Laher, Fatima Tomaras, Georgia D Cohen, Kristen W Allen, Mary Malahleha, Mookho Mngadi, Kathryn Daniels, Brodie Innes, Craig Bentley, Carter Frahm, Nicole Morris, Daryl E Morris, Lynn Mkhize, Nonhlanhla N Montefiori, David C Sarzotti-Kelsoe, Marcella Grant, Shannon Yu, Chenchen Mehra, Vijay L Pensiero, Michael N Phogat, Sanjay DiazGranados, Carlos A Barnett, Susan W Kanesa-thasan, Niranjan Koutsoukos, Marguerite Michael, Nelson L Robb, Merlin L Kublin, James G Gilbert, Peter B Corey, Lawrence Gray, Glenda E McElrath, M Juliana
Verschenen in:
The Lancet. HIV
Paginering:
Jaargang 5 () nr. 7 pagina's e366-e378
Jaar:
2018
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license